Alembic Ltd

Stage 2 · Advancing · week 4Setup 5.5 ★ FairStrong +5.9

Alembic Limited engages in real estate business in India and internationally. More about the company

₹103.6
-1.35% today
₹2,659 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-7.0%
₹70.9 lo₹111.4 hi
7.0% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 4
1w13w26w
Week 4 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
11.8%
200 DMA: ₹92.6 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.24x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
MA20 gently rising · +1.8% vs MA50 +6.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-7.0%
3M
+17.9%
6M
+29.0%
YTD
+1.7%
1Y
+3.1%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #59 of 77 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #47 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 18w
S2 16w
S2 19w
S4 14w
S4 41w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 18w → S3 1w → S2 16w → S3 11w → S2 19w → S3 11w → S2 3w → S3 3w → S4 14w → S1 11w → S2 2w → S4 41w → S1 7w → S4 4w → S1 2w → S2 4w current
Total tracked: 168 weeks across 16 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Breakout Watch
Latest: 2026-09-08
24 appearances in last 60 days. First seen: 2024-06-04.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 4 · Vol 0.24x
2026-10-06S2
Wk 4 · Vol 0.23x
2026-10-05S2
Wk 4 · Vol 0.36x
2026-10-01S2
Wk 4 · Vol 0.59x
2026-09-30S2
Wk 4 · Vol 0.56x
2026-09-29S2
Wk 3 · Vol 1.35x
2026-09-28S2
Wk 3 · Vol 0.59x
2026-09-25S2
Wk 3 · Vol 0.53x
2026-09-24S2
Wk 3 · Vol 0.89x
2026-09-23S2
Wk 3 · Vol 0.51x
2026-09-22S2
Wk 2 · Vol 0.52x
2026-09-21S2
Wk 2 · Vol 0.29x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹97.9
200 DMA
₹92.6
52W High
₹111.4
52W Low
₹70.9
5D Low
₹103.6
Resistance levels (recent highs)
20d High
₹109.7
60d High
₹111.4
120d High
₹111.4
250d High
₹111.4
Next resistance
+5.9%
to 20d High
Ask the Market AI about ALEMBICLTDAsk →
P/E (TTM)
7.0
Forward 1.7
Earnings Growth (YoY)
-2.2%
Revenue -0.4%
ROE
+13.3%
Profit margin +132.2%
Dividend Yield
2.73%
P/B 0.9
About this companyHealth Care· Pharmaceuticals

Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, entrepreneurs, corporates, business houses, HNIs, NRIs, and pharmaceutical companies. The company was incorporated in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.